The eŠects of concomitant antiepileptic drugs on the serum carbamazepine concentration (C t ) were analyzed quantitatively. Primidone (PRM), phenobarbital (PB), phenytoin (PHT), valproic acid (VPA), zonisamide (ZNS), clonazepam (CZP), and ethosuximide (ETS) were coadministered with carbamazepine (CBZ). Routine therapeutic drug monitoring data, obtained from epileptic patients who were treated with the repetitive oral administration of CBẐ ne granules/tablets, were used for the analysis. A total of 119 patients were administered CBZ alone, and 91, 39, 19, and 6 patients were coadministered one, two, three, and more than four diŠerent antiepileptic drugs, respectively. Using the data obtained from the patients administered CBZ alone, C t could be expressed approximately as a function of the daily dose per extracellular water volume (D/V ECW ) as C t ＝A(D/V ECW ) B (A, B: parameter). By comparing the regression line on log C t vs. log(D/V ECW ) for CBZ alone with that for CBZ plus another concomitant drug, C t was thus found to be aŠected at each deˆnite ratio by PB and PHT, but not by VPA and ZNS. We postulated a model showing that C t is aŠected by each concomitant antiepileptic drug i at each deˆnite ratio. We deˆned the parameter R i (i＝1, 2, …, 7) representing the eŠect of each concomitant antiepileptic drug on C t . A linear polynomial expression, in which both members of this model are converted into common logarithms, was used for a multiple regression analysis. The analysis claried that PB and PHT lowered C t to 0.770 and 0.710 the value of CBZ alone, respectively. On the other hand, VPA and ZNS did not aŠect C t . The number of patients coadministered PRM, CZP, and/or ETS was not su‹cient to detect the eŠect on C t based on a test of signiˆcance. In the case of the addition or discontinuation of concomitant antiepileptic drugs in the same patient, the estimated C t values were calculated using the value of each R i and compared with the measured C t values. Both values were in good agreement, and thus our results appear valid.
INTRODUCTION
Carbamazepine (CBZ) is widely used for the treatment of epilepsy. Many reports have referred to the changes in CBZ disposition caused by other concomitant antiepileptic drugs. [1] [2] [3] In those reports, when the serum CBZ concentration (C t ) was compared with the daily dose per body weight (D/W), C t was aŠected by confounding factors such as age and sex. 4, 5) A signiˆcant positive correlation was also observed between age and the level-dose (LD) ratio C t / (D/W). 6, 7) The relationship between C t and the daily dose has not been assessed directly. The regression line for C t against D/W, which does not intersect the origin, was used for the analysis. Concerning the eŠects of concomitant antiepileptic drugs on C t , LD ratios were merely compared 8, 9) and the eŠects were not evaluated quantitatively.
In our previous paper, 10) multiple regression analysis conˆrmed that C t could only be correlated with the daily dose per extracellular water volume. In this study, we assumed that C t was expressed as a power function of the daily dose per extracellular water volume and investigated which concomitant antiepileptic drugs aŠected C t using a power function, in the same way as we investigated for valproic acid (VPA). 11, 12) We showed the eŠects of concomitant antiepileptic drugs on C t quantitatively, making it possible to estimate the changes in C t values without grouping by other factors when the concomitant antiepileptic drugs are changed. 
METHOD
We collected data from epileptic patients who were chronically treated with repetitive oral administration of CBZ (Tegretolgranules/tablets, Novartis Pharma, Tokyo, Japan) at both Kagawa Medical University Hospital and Kurashiki Central Hospital from April 1996 to March 1997. Patients with abnormal ndings on hepatic and renal function tests were excluded. All patients had been administered CBZ for more than 3 months. Blood samples were drawn 2 to 3 h after the last dosing in outpatients and 2 to 15 h after the last dosing in inpatients. When there were plural measurements for C t in one patient with the same prescribed drugs during the study period, the mean value of C t was used as the representative one. The age, body weight, height, and daily CBZ dose were also treated in the same manner. When there were several varieties of prescribed drugs in one patient, the count was taken as the number of patients. C t was measured in duplicate using the FPIA method (TDX or FLX system, DAINABOT, Tokyo, Japan) and employed the mean value.
Data analysis was performed utilizing the statistical package NAP(ver.4). 13) Table 1 shows the characteristics of the patients administered CBZ in each hospital. Age and C t were signiˆcantly diŠerent and the eŠect of both variables on the analysis are uncertain, but we assembled the data to elevate the potential of detection in the analysis. 2. EŠects of Concomitant Antiepileptic Drugs on C t (1) C t for CBZ Alone
RESULTS

Patient Characteristics
In the previous paper, 10) we investigated the most suitable transforming factor to relate the daily CBZ dose (D) with the C t for CBZ alone. Four types of transforming factor corresponding to clearance, i.e., body weight, total body water volume, body surface area, and extracellular water volume (V ECW ) were used. Multiple regression analysis conˆrmed that C t was only dependent on D/V ECW . V ECW was estimated by the following empirical formula 14) :
In Fig. 1 , the plots show the relationship between D /V ECW and C t for CBZ alone. It appears that the increment in C t decreases gradually with the increase in 
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We postulated the convenient Eq. (1), in which C t is proportional to the power function of D/ V ECW . Using a nonlinear least-squares method, parameters A and B were estimated to be 0.928 and 0.517, respectively.
(2) C t for CBZ Plus Another Antiepileptic Drug The eŠects of concomitant antiepileptic drugs on the C t of CBZ were investigated. Ninety-one patients were coadministered one of six antiepileptics drug with CBZ, i.e., phenobarbital (PB), phenytoin (PHT), VPA, zonisamide (ZNS), clonazepam (CZP), and ethosuximide (ETS) were coadministered ( Table 2) .
We assumed that Eq. (1) could be adapted to express C t in the coadministration of another antiepileptic drug with CBZ. Both members of Eq. (1) were converted into common logarithms, y＝a＋bx (2) where y＝log C t , x＝log(D/V ECW ), a＝log A, and b ＝B. The dose of concomitant antiepileptic drugs was not considered in this assumption. For simple regression analysis, y and x were assigned to be a criterion variable and an explanatory one, respectively. Then a and b were estimated. Figure 2 shows the plots and regression lines of log C t against log(D/V ECW ) for CBZ alone and for the concomitant use of PB, PHT, VPA, and ZNS. The regression lines and the sample standard deviations from the regression lines (S y ) are shown in Table 2 . The number of patients coadministered PRM, CZP, or ETS with CBZ was not su‹cient to calculate the regression line.
A statistical method 15) was used to compare the regression line 0 for CBZ alone with line I (I＝2, 3, 4, 5). The results are shown in Table 2 . For the slope, no signiˆcant diŠerence was detected between line 0 and other lines I. The slope of each line I was not diŠerent from that of line 0, and thus all the lines may be parallel. On the other hand, for the elevation, signiˆcant diŠerences were detected for PB and PHT, but not for VPA and ZNS. These results indicate that C t is aŠected at each deˆnite ratio by PB and PHT, but not by VPA and ZNS. 
where R i is a parameter representing the eŠect of each concomitant antiepileptic drug on C t with CBZ alone, i.e., A(D/V ECW ) B . Hereafter, R i is referred to as an alteration ratio. The subscript i represents the concomitant drug, and i＝1, 2, …, 7 corresponds to primidone (PRM), PB, PHT, VPA, ZNS, CZP, and ETS, respectively. z i is 1 or 0 when drug i is coadministered or not. The doses of concomitant antiepileptic drugs were not considered in this model.
In Eq. (3), C t is expressed under the assumption that the eŠects of concomitant antiepileptic drugs on C t are independent from one another and multiplicative.
When both members of Eq. (3) are converted into where y＝log C t , a＝log A, b＝B, x＝log(D/V ECW ), and r i ＝log R i . For multiple regression analysis, y and x were assigned to be a criterion variable and an explanatory one, respectively. Then a, b, and r i were estimated. The level of signiˆcance discriminating the addition and/or elimination of a variable using the Ftest was taken as 0.05. A total of 119 patients was administered CBZ alone, while 91, 39, 19, and 6 patients were coadministered one, two, three, and more than four diŠer-ent antiepileptic drugs ( Table 1) . A total of 274 cases was analyzed using Eq. (4) for multiple regression analysis. The results are shown in Table 3 .
In the multiple regression analysis, the forward selection method was used to select the variables in‰uencing C t . PB and PHT were selected as the antiepileptic drugs in‰uencing C t (to be more precise, they in‰uenced y(＝log C t )). These drugs lower C t to 0.770 and 0.710 the value for CBZ alone in concomitant use, respectively.
Multiple regression analysis with no variable selection method estimated r 5 for ZNS as -0.027, and the value is 0.941 for R. The standard deviation of r 5 was 0.023 and nearly equal to those of PB, PHT, and VPA. Thus ZNS can be said to have no eŠect on C t . PRM, CZP, and ETS altered C t to 0.932, 0.912, and 0.681, respectively, compared with the value for CBZ alone. However, multiple regression analysis using the variable selection method did not select them as drugs in‰uencing C t . Because the number of the patients administered these drugs was not su‹cient and the data were scattered widely, their eŠects on C t were not detected.
DISCUSSION
Major determinant factors of CBZ disposition are autoinduction and concomitant therapy. 16) In our patients, autoinduction could be neglected because of the su‹ciently long administration periods. 17) Numerous reports have mentioned the eŠects of concomitant antiepileptic drugs on C t , but no attention has been paid to the eŠects of confounding factors, such as age and sex. We conducted a study to clarify the eŠects of concomitant antiepileptic drugs on C t , without being aŠected by confounding factors.
When C t is not directly proportional to D/V ECW , if the power function of D/V ECW could be substituted for a regression curve, the curve could be converted into a straight line by taking logarithms of both members. Then the eŠects of concomitant antiepileptic drugs on C t could be investigated by comparing the regression line on log C t vs. log(D/V ECW ) for CBZ alone with that for CBZ plus another concomitant drug. Eq. (1) proposed in this paper represents the C t -(D/V ECW ) relation fairly well (Fig. 1) . Each distribution of residuals from Eq. (1) and Eq. (2) for CBZ alone and for CBZ＋PHT approximated a nor-mal distribution. Eq. (1) detected the eŠects of concomitant antiepileptic drugs on C t .
Parameters A and B in Eq. (1) are closely linked with the ratio of the bioavailability to the elimination rate constant, and the curvature of theˆtting curve of CBZ binding to plasma protein, 10) respectively. The eŠects of concomitant antiepileptic drugs result in diŠerences in the slope or elevation in Eq. (2), respectively. The slopes of all lines did not diŠer, but neither of the elevations for PB and PHT were equal to that of CBZ alone (Fig. 2, Table 2 ). The former result agreed with the reports that PHT, VPA, 18) and ZNS 19) did not aŠect the plasma protein binding of CBZ. The latter result indicated that A in Eq. (1) was altered by concomitant drugs. Thus C t is aŠected at each deˆnite ratio by these antiepileptic drugs. Because the bioavailability is considered to be almost constant, the change in the elimination rate would be re‰ected in each R i value.
Eq. (3) was postulated for a detailed investigation of the interactions among antiepileptic drugs. The S y value for CBZ alone in the simple regression analysis was 0.099 (Table 2) , and S y for all cases including one to more than four concomitant antiepileptic drugs was 0.119 (Table 3 , using the variable selection method). Since there is little diŠerence between both S y values, Eq. (3) is considered useful. As this model can analyze all cases inclusively, the reliability of the estimated parameters is increased.
Multiple regression analysis revealed that PB and PHT lowered C t to 0.770 and 0.710, respectively (Table 3). Our results agreed with the reports that PB and PHT lowered C t with concomitant use. 2) The result that R＜1 indicates that PB and PHT mainly increase the value of the elimination rate constant. Theseˆndings are due to the inducing actions of drug-metabolizing enzymes in these antiepileptic drugs. 9, 20) On the contrary, VPA 21) and ZNS 22) were not reported to aŠect C t , in agreement with our results. Although it was not clariˆed whether PRM aŠected C t , PRM is anticipated to lower C t due to the metabolization of PB.
When the concomitant use of PB or PHT is changed in a patient, the alteration in C t can be estimated from Eq. (3) by using the values of R 2 and R 3 ( Table 3) .
When C t(2,3) represents C t during concomitant therapy with PB, PHT, and CBZ and C t(3) represents C t during therapy with PHT and CBZ, C t(2,3) and C t (3) can be written as 
is the daily CBZ dose before discontinuation of PB, the daily CBZ dose after discontinuation should be decreased to 0.603 to maintain the same level of C t .
To evaluate the value of each R i obtained in this study, the measured and estimated values of C t were compared between the cases where the prescribed drugs were changed in the same patient. For PB and PHT, the value of each R i was obtained by multiple regression analysis using the variable selection method ( Table 3) . For PRM, VPA, ZNS, CZP, and ETS, the value of each R i was postulated to be 1. Figure 3 shows the plots of estimated C t versus measured C t values. Both values appear to be in good agreement. The mean absolute error (MAE) was calculated to be 18.7％ using the following equation. MAE(％)＝∑{(|measured value-estimated value| /measured value)/n}×100 (n: number of sets compared) Each regression line for the relationship between D /W and C t for CBZ alone, CBZ＋PHT, and CBZ＋ PB was reported. 9) The MAE calculated in the same manner was 23.1％. This value shows that better results were obtained in the present study.
Although our study was a retrospective one and our clinical data were scattered widely, we feel conˆdent of the results. Each alteration ratio of R i in our study population could be adapted to the patients without being grouped by other confounding factors. This makes it easy to estimate C t correctly with the addition or discontinuation of concomitant antiepileptic drugs during CBZ treatment of epileptic patients.
